Market & Alt Data
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | 2026-08-10 | Steik Jason Paul | Chief Clinical Officer | Sale | 1,394 | $38.52 | $54K | 15.1K | View | |
| 2026-08-06 | 2026-08-10 | Guerisoli Brent | Chief Executive Officer | Sale | 4,285 | $38.52 | $165K | 99.5K | View | |
| 2026-08-06 | 2026-08-10 | Cheney Kirk Sterling | EVP, GC and Corp Secy | Sale | 1,393 | $38.52 | $54K | 18.4K | View | |
| 2026-07-10 | 2026-07-14 | Guerisoli Brent | Chief Executive Officer | Sale | 3,159 | $41.56 | $131K | 103.8K | View | |
| 2026-07-07 | 2026-07-09 | Guerisoli Brent | Chief Executive Officer | Sale | 3,165 | $40.51 | $128K | 100.7K | View |
Informational purposes only, not investment advice.
tormere.com/research/PNTG · generated 2026-10-05
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-06 | Steik Jason Paul | S | 1,394 | $53,699.67 |
| 2026-08-06 | Guerisoli Brent | S | 4,285 | $165,066.77 |
| 2026-08-06 | Cheney Kirk Sterling | S | 1,393 | $53,661.15 |
| 2026-07-10 | Guerisoli Brent | S | 3,159 | $131,303.84 |
| 2026-07-07 | Guerisoli Brent | S | 3,165 | $128,214.15 |
Tormere — informational purposes only, not investment advice.